Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04724018
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-07
First Post:
2021-01-20
Brief Title:
Sacituzumab Govitecan Plus EV in Metastatic UC
Sponsor:
Organization:
Dana-Farber Cancer Institute